Alfresa Holdings Corporation (TYO:2784)
1,972.00
-32.00 (-1.60%)
Feb 21, 2025, 3:30 PM JST
Alfresa Holdings Revenue
Alfresa Holdings had revenue of 805.97B JPY in the quarter ending December 31, 2024, with 7.18% growth. This brings the company's revenue in the last twelve months to 2.94T, up 4.00% year-over-year. In the fiscal year ending March 31, 2024, Alfresa Holdings had annual revenue of 2.86T with 6.02% growth.
Revenue (ttm)
2,941.02B
Revenue Growth
+4.00%
P/S Ratio
0.13
Revenue / Employee
234.96M
Employees
12,517
Market Cap
363.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 2,858.50B | 162.43B | 6.02% |
Mar 31, 2023 | 2,696.07B | 110.43B | 4.27% |
Mar 31, 2022 | 2,585.64B | -17.53B | -0.67% |
Mar 31, 2021 | 2,603.17B | -95.34B | -3.53% |
Mar 31, 2020 | 2,698.51B | 58.00B | 2.20% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |